Astrazeneca to roll out ‘next generation’ vaccine for Covid mutations by autumn February 3, 2021 Astrazeneca aims to produce a “next generation” Covid-19 vaccine especially suited to new mutations as soon as the autumn, a senior executive said today. Mene Pangalos, a senior research chief at the British-Swedish firm, said Astrazeneca will start developing a new vaccine for the mutated strains and will look to make them public “as rapidly [...]
Covid-19: Oxford-Astrazeneca vaccine could cut transmission by two-thirds February 2, 2021 The Oxford University/Astrazeneca Covid-19 vaccine could cut the transmission of infections by two-thirds and a three-month delay between doses does not reduce efficacy, a new report has found. A pre-print paper published by Oxford and the Lancet found there was a 67 per cent reduction in positive swabs among those vaccinated. The research also found [...]
EU approves Astrazeneca vaccine for all over-18s January 29, 2021 The EU drugs regulator has approved the use of the Astrazeneca Covid vaccine for all people over the age of 18. The green light from the European Medicines Agency means Astrazeneca vaccine is the third to be approved by the EU, after those developed by Pfizer/Biontech and Moderna. The move follows an increasingly bitter dispute [...]
EU says AstraZeneca contract contains ‘binding orders’ as vaccine row intensifies January 29, 2021 The European Union’s contract with AstraZeneca for its Covid-19 vaccine contains binding orders, the EU Commission head said on Friday. Ursula von der Leyen has demanded a plausible explanation from the UK-based vaccine maker for delivery hold-ups, describing the contract as “crystal clear”. AstraZeneca CEO Pascal Soriot defended the drug maker earlier this week, claiming [...]
EU and AstraZeneca hold crisis talks to resolve Covid vaccines row January 28, 2021 The EU and UK-based Covid vaccine maker AstraZeneca have vowed to resolve clashes over supply shortages after “constructive” crisis talks. Production issues means that AstraZeneca can deliver only a fraction of the doses promised to the EU in the first quarter of the year, leading to shortages across the 27-member bloc. The EU has remained [...]
Covid-19 has shown it is time to invest in Britain’s scientists January 6, 2021 Let’s start the New Year with a very positive point. The speed of scientific innovation seems to be accelerating sharply. And it is innovation which ultimately drives our health, wealth and well-being. The types of problems which have previously taken years or even decades to solve are being cracked in record times. The development of [...]
UK begins rollout of Oxford-Astrazeneca Covid-19 vaccine January 4, 2021 The UK will today begin Covid-19 vaccinations using the vaccine developed by Astrazeneca and the University of Oxford. Britain last week became the first country in the world to authorise the use of the vaccine after it was given the green light by the Medicines and Healthcare products Regulatory Agency (MHRA). The government has secured [...]
Astrazeneca vaccine could help ease Covid restrictions, minister says December 28, 2020 Regulatory approval of the Covid-19 vaccine developed by Astrazeneca and Oxford University could accelerate the easing of lockdown measures, the government has said. Cabinet Office minister Michael Gove said there would be a “significant increase” in jabs available if authorities give the green light to the British vaccine candidate. This would allow ministers to ease [...]
Astrazeneca vaccine ‘safe and effective’, study finds December 8, 2020 The Astrazeneca/Oxford University vaccine is safe and effective in vaccinating people against coronavirus, independent analysis has confirmed.
Astrazeneca sells cholesterol drug to German firm for $320m December 1, 2020 Astrazeneca has announced that it will sell the rights to its blockbuster cholesterol drug to German firm Gruenenthal GmbH for $320m (£240m). The drug, which is called Crestor, used to be one of the pharma giant’s bestselling medicines, bringing in $5bn in revenue in 2015. However, with the marketplace now crowded with alternative treatments, the [...]